- Covers the latest clinical advances and relevant discussions—Biomarkers, Genomics, and Surrogate Outcomes in MS; Pediatric MS; Transverse Myelitis; Attack Therapies in MS; Current Disease-Modifying Therapeutic Strategies in MS; Management of Aggressive MS; Symptomatic Therapies in MS; Complementary and Alternative Medical Therapies; and Strategies to Promote Neuroprotection and Repair—to bring you up to date and keep your practice state-of-the-art.
- Features a greater emphasis on practical management to help you determine the type of multiple sclerosis and the best course of therapy.
- Focuses on pharmaceutical therapies so you know the best and most aggressive methods and which drugs to use for treatment.
- Includes extensive information on differential diagnosis so that you can clearly distinguish between multiple sclerosis and other similar demyelinating disorders.
- Presents expert new editors and experienced contributing authors for the most current and relevant practice information.
- Emphasizes the pharmacologic management of patients with multiple sclerosis to address treating the actual disease and its relapses as well as treating the symptoms.
Table of Contents:
Contributing Authors
Series Preface
Preface
1. Clinical Features and Natural History of Multiple Sclerosis: The Nature of the Beast
2. Differential Diagnosis and Diagnostic Criteria for Multiple Sclerosis: Application and Pitfalls
3. Uncovering the Genetic Architecture of Multiple Sclerosis
4. Epidemiology of Multiple Sclerosis: Environmental Factors
5. Advances in Multiple Sclerosis Imaging
6. Biomarkers in Multiple Sclerosis
7. Cognitive and Psychiatric Disorders in Multiple Sclerosis
8. Gender Issues and Multiple Sclerosis
9. Pediatric Multiple Sclerosis
10. Clinically Isolated Syndromes
11. Acute Disseminated Encephalomyelitis
12. Transvers Myelitis: Pathogenesis, Diagnosis, and Management
13. Neuromyelitis Optica
14. Attack Therapies in Multiple Sclerosis
15. Current Disease-Modifying Therapeutic Strategies in Multiple Sclerosis
16. Management of Aggressive Multiple Sclerosis: Options and Challenges
17. Symptomatic Therapy in Multiple Sclerosis
18. Unconventional Medicine and Multiple Sclerosis: The Role of Conventional Health Providers
19. Is Multiple Sclerosis a Neurodegenerative Disorder?
20. Lessons from the Past and Future Approaches for Immunologic Therapies in Multiple Sclerosis
21. Strategies to Promote Neuroprotection and Repair in Multiple Sclerosis
Index
